Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Semin Oncol. 2014 Jul 21;41(5):589–612. doi: 10.1053/j.seminoncol.2014.07.003

Table 3.

Binding kinetics of mouse 3F8 and hu3F8 antibodies to human FcγRII (CD32)

Antibody kon (1/Ms) SD koff (1/s) SD KA=kon/koff koff (relative to CD32A-131R) KA (relative to CD32A-131R)
mouse 3F8 (IgG3) CD32A-131R 2.59E+04 9.31E+03 3.63E-01 2.36E-02 7.15E+04 1 1
CD32A-131H 1.90E+04 3.58E+03 1.10E+00 8.27E-02 1.73E+04 3.02 0.24
CD32B 1.15E+04 1.60E+03 2.03E+00 3.78E-01 5.66E+03 5.6 0.08

hu3F8 (IgG1) CD32A-131R 1.49E+05 4.38E+04 4.06E-01 4.94E-02 3.68E+05 1.12 5.15
CD32A-131H 2.70E+05 9.48E+03 4.27E-01 3.59E-02 6.31E+05 1.18 8.83
CD32B 2.86E+04 1.63E+04 3.41E-01 2.63E-01 8.37E+04 0.94 1.17
*

Kinetics of FcγRII (CD32) interaction with mouse 3F8 and hu3F8 were measured using a Biacore T100 biosensor and CM5 sensor chips (Biacore AB of GE Healthcare, Uppsala, Sweden). Toward the CD32A-131R allele, 3F8 had 2.67 fold slower off rate (koff), and nearly 3-fold higher binding affinity (Ka) than toward CD32A-131H. For hu3F8, the high affinity allele was 131-H. Affinity for CD32B was much lower for mouse 3F8 than for hu3F8.